Tiny study on vaccine response in heart transplant patients ends early

NCT ID NCT04845945

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study aimed to measure how well heart transplant candidates and recipients respond to standard pneumococcal vaccines using two blood tests. Only 4 people enrolled before the study was terminated. Because it was so small, it provides very limited information about vaccine effectiveness in this group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

PCV15 and PPSV23 (pneumococcal vaccines)

What this could lead to

If successful, this could help doctors understand if standard pneumococcal vaccines work well in heart transplant patients.

What could go wrong

The study was terminated early with only 4 participants, so results are very limited and may not apply to others.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART TRANSPLANT INFECTION PREVENTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Montefiore Medical Center, Infectious Diseases

    The Bronx, New York, 10467, United States